|
Volumn 47, Issue 11 11A, 1997, Pages 1329-1331
|
Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia
a b c d e f a a b c d e f a a b c d e f more.. |
Author keywords
CAS 69542 93 4; Corticotropm releasing factor; Improvement of neurasthenia; Neurasthenia; Pivagabine; Tonerg
|
Indexed keywords
PIVAGABINE;
PLACEBO;
PSYCHOTROPIC AGENT;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DYSTHYMIA;
FATIGUE;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NEURASTHENIA;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
WELLBEING;
ADOLESCENT;
ADULT;
AGED;
DOUBLE-BLIND METHOD;
FEMALE;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
MALE;
MIDDLE AGED;
NEURASTHENIA;
PSYCHIATRIC STATUS RATING SCALES;
PSYCHOTROPIC DRUGS;
|
EID: 0031466547
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (10)
|